Dolby Laboratories (DLB) Other financing activities (2009 - 2026)

Dolby Laboratories (DLB) has reported Other financing activities for 18 consecutive years, with $9.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities fell 25.21% year-over-year to $9.4 million; the trailing twelve-month figure through Jun 2026 stood at $29.7 million (down 24.61% YoY), and the FY2025 full-year result was $43.7 million, up 8.69% from the prior year.
• Other financing activities improved to $9.4 million in Q2 2026 per DLB's latest filing, from $1.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $22.2 million in Q4 2024 and bottomed at $716000.0 in Q3 2024.
• Historically, Other financing activities has averaged $10.7 million across 5 years, with a median of $10.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Other financing activities slumped 93.21% in 2024, then soared 600.56% in 2025.
• Over 5 years, Other financing activities stood at $11.0 million in 2022, then soared by 67.07% to $18.3 million in 2023, then gained by 21.07% to $22.2 million in 2024, then plunged by 35.67% to $14.3 million in 2025, then tumbled by 34.11% to $9.4 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $9.4 million, $1.0 million, and $14.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.